Subscribe
COVID-19 Miniseries Episode 51: Mayo Clinic Q&A – Bringing COVID-19 Vaccines to the Public

Mayo Clinic Talks

COVID-19 Miniseries Episode 51: Mayo Clinic Q&A – Bringing COVID-19 Vaccines to the Public

This episode is shared from Mayo Clinic Q&A and was recorded on September 14, 2020. To claim credit visit: https://ce.mayo.edu/covid19podcast Guest:  Gregory A. Poland, M.D. (@drgregpoland) Host: Danielle Stiepan Once a vaccine to prevent…
September 17, 2020
ADVERTISEMENT
WP Engine Wordpress Hosting

COVID-19 Miniseries Episode 51: Mayo Clinic Q&A – Bringing COVID-19 Vaccines to the Public

This episode is shared from Mayo Clinic Q&A and was recorded on September 14, 2020. 

To claim credit visit: https://ce.mayo.edu/covid19podcast 

Guest:  Gregory A. Poland, M.D. (@drgregpoland) 

Host: Danielle Stiepan 

Once a vaccine to prevent COVID-19 is approved, there will be logistics to consider. For example, who will receive the vaccine first, and how can the supply chain safely deliver the vaccine to 330 million Americans and potentially more than 7 billion people worldwide? In addition, multiple vaccines may be brought to market within weeks to months of each other, confusing consumers. 

On the Mayo Clinic Q&A podcast, Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic’s Vaccine Research Group, explains the challenges of rolling out a COVID-19 vaccine. 

AskMayoExpert COVID-19 Resources: https://askmayoexpert.mayoclinic.org/navigator/COVID-19 

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd

ADVERTISEMENT
Wise-Formerly Transferwise

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Javier Lozano - Market-Creating Innovation for Diabetes Care an inspiring conversation with Javier Lozano, Founder and CEO of Clínicas del Azúcar, a growing chain of "one-stop shops" for diabetes care in Mexico.